Biotech

All Articles

Pfizer takes $230M hit after axing neglected DMD gene treatment

.Pfizer's period 3 Duchenne muscular dystrophy (DMD) genetics treatment failure has gone a $230 thou...

AC Immune sees 'landmark' possible in Alzheimer's drug information

.After greater than two decades of work with neurodegenerative health conditions, Swiss biotech hvac...

GSK loses ph. 2 HPV vaccination over shortage of best-in-class possible

.GSK has broken up a stage 2 individual papillomavirus (HPV) vaccination from its own pipeline after...

OS Therapies refiles $6M IPO to finance HER2 medicine, preclinical ADCs

.OS Therapies will definitely provide on the NYSE American stock swap today using a $6.4 million IPO...

ALX's fizzling CD47 reaction fee sends sell spiraling down

.ALX Oncology's period 2 stomach cancer cells feedback rate has deteriorated. After seeing its CD47 ...

Ionis centers eye ailment from targets of Roche-partnered prospect after data disappoint

.Yet Another of Ionis Pharmaceuticals' essential midphase readouts has disappointed expectations, tr...

Biogen's chief executive officer mentioned no unsafe sell 2023. He prepares to become daring

.While Biogen's pharma peers are actually searching for late-stage possessions along with little bit...

Instil refills pipe in $2B biobucks handle ImmunOnco

.Instil Biography has actually been actually a biotech looking for a pipe after it ditched its lead ...

Biogen bows out Denali Alzheimer's collab

.Biogen has actually handed back liberties to a very early Alzheimer's condition system to Denali Th...

Takeda water faucets brand-new head of US oncology company-- Chutes &amp Ladders

.Accept to recently's Chutes &amp Ladders, our roundup of significant leadership hirings, shootings ...